Morgan Stanley’s Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 CPUH.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-190
Closed -$95 7807
2023
Q2
$95 Buy
190
+65
+52% +$24 ﹤0.01% 7499
2023
Q1
$50 Hold
125
﹤0.01% 7609
2022
Q4
$14 Buy
+125
New +$14 ﹤0.01% 7791

Morgan Stanley's CPUH.WS Position: Q3 2023 in Review

Morgan Stanley sold out of Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (CPUH.WS) in Q3 2023, closing a stake of 190 shares — an estimated $95 sold.

Morgan Stanley first reported a position in CPUH.WS in Q4 2022 and held it in 3 quarters. The position peaked at $95 in Q2 2023. 0 funds tracked by Wall St. Rank hold CPUH.WS as of Q3 2023.

  • Morgan Stanley reported no remaining Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q3 2023 after selling out during the quarter.
  • Morgan Stanley sold 190 Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q3 2023, an estimated $95.
  • Morgan Stanley first reported a position in Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q4 2022 and held it in 3 quarters.
  • Morgan Stanley's Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $95 in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q3 2023.

Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.